Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis factor H binding protein (fHbp) is a surface-exposed lipoprotein found on the bacterium *Neisseria meningitidis*, a major cause of bacterial meningitis and sepsis worldwide. fHbp plays a critical role in immune evasion by binding to human complement factor H (CFH), thereby protecting the bacterium from complement-mediated killing. It is an important protective antigen included as a key component in two licensed vaccines against serogroup B *N. meningitidis* (MenB).
Vaccines elicit antibodies that block CFH binding or promote bactericidal activity via complement activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis factor H binding protein (fHbp).